Dr. Kinlaw is a biochemist and molecular plant geneticis. As Chief Science Officer at Zea Biosciences, Dr. Kinlaw drives the company’s earliest evaluation of drug candidates, oversees the company’s researcher partnerships, and directs the utilization of Zea’s Lighthouse Platform Technology. Before joining Zea, Dr. Kinlaw worked for the Danforth Plant Science Center as their Director of Innovation Commercialization, bridging plant science discoveries to the marketplace for commercial solutions in agriculture and managed Danforth’s partnership in the agriculture innovation track of the virtual incubator, IN2.

Prior, she has held early leadership roles in several early-stage companies, notably TerViva, a company dedicated to commercializing an environmentally friendly tree crop for plant-based protein. In addition, Dr. Kinlaw has advised scores of early-stage companies in agriculture and renewable energy in developing commercial strategies. She holds a Ph.D. in biochemistry and an MBA from UC Berkeley Haas school of management.

Dr. Kinlaw is passionate about unlocking access to new drug therapies in developed economies and those left out of current biotechnology advances.